BidaskClub cut shares of LHC Group (NASDAQ:LHCG) from a buy rating to a hold rating in a report published on Tuesday, July 25th.
A number of other brokerages have also recently issued reports on LHCG. Zacks Investment Research cut shares of LHC Group from a buy rating to a hold rating in a report on Thursday, July 6th. Royal Bank Of Canada reissued a buy rating on shares of LHC Group in a report on Tuesday, June 13th. Jefferies Group LLC reissued a buy rating and set a $65.00 target price on shares of LHC Group in a report on Friday, June 9th. Benchmark Co. boosted their target price on shares of LHC Group from $63.00 to $72.00 and gave the company a buy rating in a report on Thursday, June 8th. Finally, Oppenheimer Holdings, Inc. reissued an outperform rating and set a $68.00 target price (up previously from $55.00) on shares of LHC Group in a report on Monday, May 8th. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The stock has an average rating of Buy and an average target price of $65.75.
Shares of LHC Group (LHCG) traded up 1.12% during midday trading on Tuesday, reaching $63.87. The company had a trading volume of 117,989 shares. The firm has a market capitalization of $1.17 billion, a P/E ratio of 28.26 and a beta of 0.77. The company has a 50 day moving average price of $63.64 and a 200-day moving average price of $56.84. LHC Group has a one year low of $32.04 and a one year high of $69.35.
LHC Group (NASDAQ:LHCG) last issued its earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.09. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. The business had revenue of $260.20 million for the quarter, compared to analysts’ expectations of $254.10 million. During the same quarter in the previous year, the firm posted $0.52 EPS. The business’s revenue for the quarter was up 15.1% compared to the same quarter last year. On average, analysts anticipate that LHC Group will post $2.39 EPS for the current fiscal year.
In other news, Director Coliseum Capital Management, L sold 14,450 shares of the company’s stock in a transaction on Friday, June 16th. The shares were sold at an average price of $65.69, for a total value of $949,220.50. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO Donald Dwayne Stelly sold 3,181 shares of the company’s stock in a transaction on Thursday, June 8th. The stock was sold at an average price of $64.97, for a total transaction of $206,669.57. Following the completion of the transaction, the chief operating officer now owns 114,235 shares of the company’s stock, valued at $7,421,847.95. The disclosure for this sale can be found here. In the last ninety days, insiders sold 554,839 shares of company stock worth $34,333,811. Insiders own 14.80% of the company’s stock.
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Russell Investments Group Ltd. bought a new position in shares of LHC Group during the fourth quarter valued at about $1,535,000. Comerica Bank raised its position in shares of LHC Group by 5.8% in the fourth quarter. Comerica Bank now owns 15,836 shares of the health services provider’s stock valued at $732,000 after buying an additional 863 shares during the period. State Street Corp raised its position in shares of LHC Group by 7.8% in the fourth quarter. State Street Corp now owns 373,936 shares of the health services provider’s stock valued at $17,094,000 after buying an additional 26,915 shares during the period. Thrivent Financial for Lutherans raised its position in shares of LHC Group by 5.9% in the fourth quarter. Thrivent Financial for Lutherans now owns 8,050 shares of the health services provider’s stock valued at $368,000 after buying an additional 450 shares during the period. Finally, Norges Bank acquired a new stake in LHC Group during the fourth quarter valued at about $7,913,000. Institutional investors own 84.97% of the company’s stock.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.